Lisdexamfetamine Dimesylate

Lisdexamfetamine Dimesylate
Product Description

Lisdexamfetamine Dimesylate is a central nervous system (CNS) stimulant active pharmaceutical ingredient (API) and prodrug indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and binge eating disorder (BED). Enzymatically hydrolyzed in red blood cells to release active dextroamphetamine, it provides extended therapeutic control with reduced potential for misuse. Ideal for formulating oral solid dosage forms.
Key Intermediates Available: 
• Dexamphetamine Hydrochloride
• Dexamphetamine Tartrate 
• Bis(tert-Butoxycarbonyl) Lisdexamphetamine

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy

More Products from CLEARSYNTH LABS LIMITED (62)

  • Methyl boronic-d3

    Product Methyl boronic-d3

    Methylboronic Acid-d₃ (CD₃B(OH)₂) is a high-purity deuterated organoboron building block widely used in the synthesis of stable isotope-labeled pharmaceuticals, advanced intermediates, and analytical reference standards. It is an essential reagent for Suzuki–Miyaura cross-coupling reactions, enabling the e...
  • Methyl iodide-d3

    Product Methyl iodide-d3

    Methyl iodide-d₃ (CD₃I) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, metabolites, and analytical reference standards. It enables the efficient incorporation of a deuterated methyl (–CD₃) group into complex organic mol...
  • Methyl tosylate-d3

    Product Methyl tosylate-d3

    Methyl Tosylate-d₃ (CD₃OTs) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated methyl (–CD₃) group into target molecules, making it a...
  • Methylamine-d3 HCl

    Product Methylamine-d3 HCl

    Methylamine-d₃ Hydrochloride serves as a key deuterated building block for introducing a CD₃-labeled methylamine moiety into complex organic molecules. It is extensively used in the preparation of deuterated drug candidates, impurities, and metabolites, including compounds such as: Deucravacitinib-d₃ ...
  • Tert-butanol-d10

    Product Tert-butanol-d10

    Tert-Butanol-d₁₀ ((CD₃)₃COD) is a high-purity deuterated alcohol widely used as a solvent and isotope-labeled building block for the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It provides an efficient source of deuterium for the preparation of de...
  • Deutetrabenazine Intermediate - 2-(3,4-bis(methoxy-d3)phenyl)ethan-1-amine

    Product Deutetrabenazine Intermediate - 2-(3,4-bis(methoxy-d3)phenyl)ethan-1-amine

    2-(3,4-bis(methoxy-d3)phenyl)ethan-1-amine is an advanced deuterated intermediate essential for the commercial synthesis and manufacturing of Deutetrabenazine (API)
  • Deuterated Products

    Product Deuterated Products

    Specialised in Deuterium Chemistry, Clearsynth Manufactures Deuterated Reagents, Deuterated Intermediates and Deuterated APIs (such as Deutetrabenazine, Deuruxolitinib, Deutivacaftor, Deucravacitinib, Donafenib)

    Production capacity from mg to tons scale.

    Our key reagents are Benzene D...
  • Nitrosamine and Drug Impurities | Testing and Analytical Services

    Product Nitrosamine and Drug Impurities | Testing and Analytical Services

    Clearsynth is a globally trusted partner for reference standards and research chemicals. We offer over 3,000 nitrosamine impurities, 5,000+ stable isotopes, and 10,000+ drug impurities, encompassing a vast portfolio of more than 325,000 products serving various industries, including pharmaceuticals, clinic...
  • Reference Standards and NMR Solvents

    Product Reference Standards and NMR Solvents

    Clearsynth is Globally Trusted Partner for Reference Standards and Research Chemicals. An extensive range of 325,000+ products serves various industries such as pharma, clinical research, testing laboratories, etc. We specialize in Innovative Organic Chemistry and synthesis of Unique Complex Molecules, St...
  • rac-cis-Ambroxol-d5

    Product rac-cis-Ambroxol-d5

    Labelled anaologue of cis-Ambroxol, the cis-isomeric impurity of Ambroxol. cis-Ambroxol is a metabolite Bromhexine.
  • L-2-Aminobutanol-d5

    Product L-2-Aminobutanol-d5

    Molecular formula: C₄H₆D₅NOMolecular weight: 94.17
  • Amisulpride-d5 N-Oxide

    Product Amisulpride-d5 N-Oxide

    Labelled Amisulpride N-Oxide. Amisulpride N-Oxide is an impurity of Amisulpride. Amisulpride N-Oxide was identified as a photodegradation product of Amisulpride.

CLEARSYNTH LABS LIMITED resources (1)

  • Video Clearsynth Intro Video

    Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.